World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Kommuniké från extra bolagsstämma i Xbrane Biopharma
Read more >> -
Announcement from Xbrane Biopharma's extra general meeting
Read more >> -
Xbrane Biopharma: Kommentar till kallelse till extra bolagsstämma
Read more >> -
Xbrane Biopharma: Comment to call for an extraordinary general meeting
Read more >> -
Xbrane Biopharma AB: Kallelse till extra bolagsstämma i Xbrane Biopharma AB
Read more >>
X
